Back to Journals » International Journal of Nanomedicine » Volume 12

Original Research

A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects

         
Total article views   Abstract views HTML views PDF downloads Totals
6,355 Dovepress* 4,800 881+ 1,197 5,681
PubMed Central* 0 674 225 674
Totals 4,800 1,555 1,422 6,355
*Since 20 March 2017
+Since July 2016

View citations on PubMed Central and Google Scholar